Natco Pharma says US District Court issues a selection in favour of Pharmacyclics by admin- Friday, August 20th, 2021 04:03:41 PM
Natco Pharma pronounces that a US District Court has issued a choice in favour of Pharmacyclics (a subsidiary of AbbVie), the brand proprietor of Imbruvica in a PIV
litigation involving the product.
NATCO and its marketing partner in US for the product, Alvogen Pine Brook LLC, USA, shall evaluation the judgement and compare all alternatives to appeal the judgement. The enterprise trust that they have a sturdy case and could keep to defend vigorously.
In the year 2018 NATCO and Alvogen, have filed an Abbreviated New Drug Application (ANDA) with PIV certification for customary version of the product.